nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—CYP3A4—Thiotepa—sarcoma	0.208	0.458	CbGbCtD
Methylergometrine—CYP3A4—Mitoxantrone—sarcoma	0.0893	0.197	CbGbCtD
Methylergometrine—CYP3A4—Vincristine—sarcoma	0.0615	0.136	CbGbCtD
Methylergometrine—CYP3A4—Etoposide—sarcoma	0.0563	0.124	CbGbCtD
Methylergometrine—CYP3A4—Doxorubicin—sarcoma	0.0384	0.0847	CbGbCtD
Methylergometrine—Haematuria—Thiotepa—sarcoma	0.00868	0.0159	CcSEcCtD
Methylergometrine—Sweating increased—Mitoxantrone—sarcoma	0.00859	0.0157	CcSEcCtD
Methylergometrine—Hallucination—Thiotepa—sarcoma	0.00813	0.0149	CcSEcCtD
Methylergometrine—Tinnitus—Thiotepa—sarcoma	0.00762	0.0139	CcSEcCtD
Methylergometrine—Cardiac disorder—Thiotepa—sarcoma	0.00759	0.0139	CcSEcCtD
Methylergometrine—Haematuria—Mitoxantrone—sarcoma	0.0075	0.0137	CcSEcCtD
Methylergometrine—Hallucination—Vincristine—sarcoma	0.00721	0.0132	CcSEcCtD
Methylergometrine—Bradycardia—Mitoxantrone—sarcoma	0.00719	0.0131	CcSEcCtD
Methylergometrine—Sweating increased—Etoposide—sarcoma	0.00714	0.0131	CcSEcCtD
Methylergometrine—Atrioventricular block—Epirubicin—sarcoma	0.00676	0.0124	CcSEcCtD
Methylergometrine—Cardiac disorder—Vincristine—sarcoma	0.00673	0.0123	CcSEcCtD
Methylergometrine—Ventricular tachycardia—Epirubicin—sarcoma	0.00655	0.012	CcSEcCtD
Methylergometrine—Atrioventricular block—Doxorubicin—sarcoma	0.00625	0.0114	CcSEcCtD
Methylergometrine—Convulsion—Thiotepa—sarcoma	0.00616	0.0113	CcSEcCtD
Methylergometrine—Hypertension—Thiotepa—sarcoma	0.00614	0.0112	CcSEcCtD
Methylergometrine—Ventricular tachycardia—Doxorubicin—sarcoma	0.00606	0.0111	CcSEcCtD
Methylergometrine—Cramps of lower extremities—Epirubicin—sarcoma	0.00602	0.011	CcSEcCtD
Methylergometrine—Nervous system disorder—Thiotepa—sarcoma	0.00569	0.0104	CcSEcCtD
Methylergometrine—Tachycardia—Thiotepa—sarcoma	0.00567	0.0104	CcSEcCtD
Methylergometrine—Cramps of lower extremities—Doxorubicin—sarcoma	0.00557	0.0102	CcSEcCtD
Methylergometrine—Thrombophlebitis—Epirubicin—sarcoma	0.0055	0.0101	CcSEcCtD
Methylergometrine—Convulsion—Vincristine—sarcoma	0.00547	0.01	CcSEcCtD
Methylergometrine—Cardiac disorder—Etoposide—sarcoma	0.00545	0.00997	CcSEcCtD
Methylergometrine—Hypertension—Vincristine—sarcoma	0.00545	0.00996	CcSEcCtD
Methylergometrine—Convulsion—Mitoxantrone—sarcoma	0.00532	0.00974	CcSEcCtD
Methylergometrine—Hypertension—Mitoxantrone—sarcoma	0.0053	0.0097	CcSEcCtD
Methylergometrine—Chest pain—Mitoxantrone—sarcoma	0.00523	0.00957	CcSEcCtD
Methylergometrine—Paraesthesia—Thiotepa—sarcoma	0.00521	0.00954	CcSEcCtD
Methylergometrine—Anaphylactic shock—Vincristine—sarcoma	0.00515	0.00942	CcSEcCtD
Methylergometrine—Thrombophlebitis—Doxorubicin—sarcoma	0.00508	0.0093	CcSEcCtD
Methylergometrine—Nervous system disorder—Vincristine—sarcoma	0.00505	0.00924	CcSEcCtD
Methylergometrine—Anaphylactic shock—Mitoxantrone—sarcoma	0.00501	0.00917	CcSEcCtD
Methylergometrine—Hyperhidrosis—Vincristine—sarcoma	0.00498	0.00911	CcSEcCtD
Methylergometrine—Muscle spasms—Etoposide—sarcoma	0.00491	0.00899	CcSEcCtD
Methylergometrine—Tachycardia—Mitoxantrone—sarcoma	0.00489	0.00895	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Epirubicin—sarcoma	0.00485	0.00888	CcSEcCtD
Methylergometrine—Hyperhidrosis—Mitoxantrone—sarcoma	0.00485	0.00887	CcSEcCtD
Methylergometrine—Hypotension—Vincristine—sarcoma	0.00481	0.0088	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Thiotepa—sarcoma	0.00475	0.00869	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Dactinomycin—sarcoma	0.00471	0.00862	CcSEcCtD
Methylergometrine—Hypotension—Mitoxantrone—sarcoma	0.00469	0.00857	CcSEcCtD
Methylergometrine—Paraesthesia—Vincristine—sarcoma	0.00462	0.00846	CcSEcCtD
Methylergometrine—Abdominal pain—Thiotepa—sarcoma	0.00459	0.0084	CcSEcCtD
Methylergometrine—Abdominal pain—Dactinomycin—sarcoma	0.00456	0.00833	CcSEcCtD
Methylergometrine—Paraesthesia—Mitoxantrone—sarcoma	0.0045	0.00824	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Doxorubicin—sarcoma	0.00449	0.00822	CcSEcCtD
Methylergometrine—Dyspnoea—Mitoxantrone—sarcoma	0.00447	0.00818	CcSEcCtD
Methylergometrine—Convulsion—Etoposide—sarcoma	0.00443	0.0081	CcSEcCtD
Methylergometrine—Hypertension—Etoposide—sarcoma	0.00441	0.00807	CcSEcCtD
Methylergometrine—Chest pain—Etoposide—sarcoma	0.00435	0.00796	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Vincristine—sarcoma	0.00421	0.0077	CcSEcCtD
Methylergometrine—Anaphylactic shock—Etoposide—sarcoma	0.00417	0.00763	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.0041	0.0075	CcSEcCtD
Methylergometrine—Tachycardia—Etoposide—sarcoma	0.00407	0.00745	CcSEcCtD
Methylergometrine—Abdominal pain—Vincristine—sarcoma	0.00407	0.00745	CcSEcCtD
Methylergometrine—Hyperhidrosis—Etoposide—sarcoma	0.00403	0.00738	CcSEcCtD
Methylergometrine—Angina pectoris—Epirubicin—sarcoma	0.00401	0.00733	CcSEcCtD
Methylergometrine—Diarrhoea—Thiotepa—sarcoma	0.00397	0.00727	CcSEcCtD
Methylergometrine—Abdominal pain—Mitoxantrone—sarcoma	0.00396	0.00725	CcSEcCtD
Methylergometrine—Diarrhoea—Dactinomycin—sarcoma	0.00394	0.00721	CcSEcCtD
Methylergometrine—Hypotension—Etoposide—sarcoma	0.0039	0.00713	CcSEcCtD
Methylergometrine—Dizziness—Thiotepa—sarcoma	0.00384	0.00702	CcSEcCtD
Methylergometrine—Paraesthesia—Etoposide—sarcoma	0.00375	0.00685	CcSEcCtD
Methylergometrine—Dyspnoea—Etoposide—sarcoma	0.00372	0.0068	CcSEcCtD
Methylergometrine—Angina pectoris—Doxorubicin—sarcoma	0.00371	0.00678	CcSEcCtD
Methylergometrine—Vomiting—Thiotepa—sarcoma	0.00369	0.00675	CcSEcCtD
Methylergometrine—Vomiting—Dactinomycin—sarcoma	0.00366	0.0067	CcSEcCtD
Methylergometrine—Rash—Thiotepa—sarcoma	0.00366	0.0067	CcSEcCtD
Methylergometrine—Dermatitis—Thiotepa—sarcoma	0.00366	0.00669	CcSEcCtD
Methylergometrine—Headache—Thiotepa—sarcoma	0.00364	0.00665	CcSEcCtD
Methylergometrine—Rash—Dactinomycin—sarcoma	0.00363	0.00665	CcSEcCtD
Methylergometrine—Diarrhoea—Vincristine—sarcoma	0.00352	0.00644	CcSEcCtD
Methylergometrine—Haematuria—Epirubicin—sarcoma	0.0035	0.00639	CcSEcCtD
Methylergometrine—Nausea—Thiotepa—sarcoma	0.00345	0.00631	CcSEcCtD
Methylergometrine—Diarrhoea—Mitoxantrone—sarcoma	0.00343	0.00628	CcSEcCtD
Methylergometrine—Nausea—Dactinomycin—sarcoma	0.00342	0.00626	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Etoposide—sarcoma	0.00341	0.00624	CcSEcCtD
Methylergometrine—Dizziness—Vincristine—sarcoma	0.0034	0.00623	CcSEcCtD
Methylergometrine—Bradycardia—Epirubicin—sarcoma	0.00335	0.00613	CcSEcCtD
Methylergometrine—Abdominal pain—Etoposide—sarcoma	0.0033	0.00603	CcSEcCtD
Methylergometrine—Vomiting—Vincristine—sarcoma	0.00327	0.00599	CcSEcCtD
Methylergometrine—Rash—Vincristine—sarcoma	0.00325	0.00594	CcSEcCtD
Methylergometrine—Dermatitis—Vincristine—sarcoma	0.00324	0.00593	CcSEcCtD
Methylergometrine—Haematuria—Doxorubicin—sarcoma	0.00323	0.00592	CcSEcCtD
Methylergometrine—Headache—Vincristine—sarcoma	0.00323	0.0059	CcSEcCtD
Methylergometrine—Vomiting—Mitoxantrone—sarcoma	0.00319	0.00583	CcSEcCtD
Methylergometrine—Rash—Mitoxantrone—sarcoma	0.00316	0.00578	CcSEcCtD
Methylergometrine—Dermatitis—Mitoxantrone—sarcoma	0.00316	0.00578	CcSEcCtD
Methylergometrine—Headache—Mitoxantrone—sarcoma	0.00314	0.00575	CcSEcCtD
Methylergometrine—Bradycardia—Doxorubicin—sarcoma	0.0031	0.00567	CcSEcCtD
Methylergometrine—Tinnitus—Epirubicin—sarcoma	0.00307	0.00561	CcSEcCtD
Methylergometrine—Nausea—Vincristine—sarcoma	0.00306	0.0056	CcSEcCtD
Methylergometrine—Cardiac disorder—Epirubicin—sarcoma	0.00305	0.00559	CcSEcCtD
Methylergometrine—Nausea—Mitoxantrone—sarcoma	0.00298	0.00545	CcSEcCtD
Methylergometrine—Diarrhoea—Etoposide—sarcoma	0.00285	0.00522	CcSEcCtD
Methylergometrine—Tinnitus—Doxorubicin—sarcoma	0.00284	0.00519	CcSEcCtD
Methylergometrine—Cardiac disorder—Doxorubicin—sarcoma	0.00283	0.00517	CcSEcCtD
Methylergometrine—Dizziness—Etoposide—sarcoma	0.00276	0.00505	CcSEcCtD
Methylergometrine—Muscle spasms—Epirubicin—sarcoma	0.00275	0.00504	CcSEcCtD
Methylergometrine—Vomiting—Etoposide—sarcoma	0.00265	0.00485	CcSEcCtD
Methylergometrine—Rash—Etoposide—sarcoma	0.00263	0.00481	CcSEcCtD
Methylergometrine—Dermatitis—Etoposide—sarcoma	0.00263	0.00481	CcSEcCtD
Methylergometrine—Headache—Etoposide—sarcoma	0.00261	0.00478	CcSEcCtD
Methylergometrine—Muscle spasms—Doxorubicin—sarcoma	0.00255	0.00466	CcSEcCtD
Methylergometrine—Palpitations—Epirubicin—sarcoma	0.00253	0.00463	CcSEcCtD
Methylergometrine—Convulsion—Epirubicin—sarcoma	0.00248	0.00454	CcSEcCtD
Methylergometrine—Nausea—Etoposide—sarcoma	0.00248	0.00453	CcSEcCtD
Methylergometrine—Hypertension—Epirubicin—sarcoma	0.00247	0.00452	CcSEcCtD
Methylergometrine—Chest pain—Epirubicin—sarcoma	0.00244	0.00446	CcSEcCtD
Methylergometrine—Palpitations—Doxorubicin—sarcoma	0.00234	0.00429	CcSEcCtD
Methylergometrine—Anaphylactic shock—Epirubicin—sarcoma	0.00234	0.00428	CcSEcCtD
Methylergometrine—Convulsion—Doxorubicin—sarcoma	0.0023	0.0042	CcSEcCtD
Methylergometrine—Nervous system disorder—Epirubicin—sarcoma	0.00229	0.00419	CcSEcCtD
Methylergometrine—Hypertension—Doxorubicin—sarcoma	0.00229	0.00419	CcSEcCtD
Methylergometrine—Tachycardia—Epirubicin—sarcoma	0.00228	0.00417	CcSEcCtD
Methylergometrine—Hyperhidrosis—Epirubicin—sarcoma	0.00226	0.00413	CcSEcCtD
Methylergometrine—Chest pain—Doxorubicin—sarcoma	0.00226	0.00413	CcSEcCtD
Methylergometrine—Hypotension—Epirubicin—sarcoma	0.00218	0.004	CcSEcCtD
Methylergometrine—Anaphylactic shock—Doxorubicin—sarcoma	0.00216	0.00396	CcSEcCtD
Methylergometrine—Nervous system disorder—Doxorubicin—sarcoma	0.00212	0.00388	CcSEcCtD
Methylergometrine—Tachycardia—Doxorubicin—sarcoma	0.00211	0.00386	CcSEcCtD
Methylergometrine—Paraesthesia—Epirubicin—sarcoma	0.0021	0.00384	CcSEcCtD
Methylergometrine—Hyperhidrosis—Doxorubicin—sarcoma	0.00209	0.00383	CcSEcCtD
Methylergometrine—Dyspnoea—Epirubicin—sarcoma	0.00208	0.00381	CcSEcCtD
Methylergometrine—Hypotension—Doxorubicin—sarcoma	0.00202	0.0037	CcSEcCtD
Methylergometrine—Paraesthesia—Doxorubicin—sarcoma	0.00194	0.00355	CcSEcCtD
Methylergometrine—Dyspnoea—Doxorubicin—sarcoma	0.00193	0.00353	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Epirubicin—sarcoma	0.00191	0.0035	CcSEcCtD
Methylergometrine—Abdominal pain—Epirubicin—sarcoma	0.00185	0.00338	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Doxorubicin—sarcoma	0.00177	0.00324	CcSEcCtD
Methylergometrine—Abdominal pain—Doxorubicin—sarcoma	0.00171	0.00313	CcSEcCtD
Methylergometrine—Diarrhoea—Epirubicin—sarcoma	0.0016	0.00293	CcSEcCtD
Methylergometrine—Dizziness—Epirubicin—sarcoma	0.00155	0.00283	CcSEcCtD
Methylergometrine—Vomiting—Epirubicin—sarcoma	0.00149	0.00272	CcSEcCtD
Methylergometrine—Diarrhoea—Doxorubicin—sarcoma	0.00148	0.00271	CcSEcCtD
Methylergometrine—Rash—Epirubicin—sarcoma	0.00147	0.0027	CcSEcCtD
Methylergometrine—Dermatitis—Epirubicin—sarcoma	0.00147	0.00269	CcSEcCtD
Methylergometrine—Headache—Epirubicin—sarcoma	0.00146	0.00268	CcSEcCtD
Methylergometrine—Dizziness—Doxorubicin—sarcoma	0.00143	0.00262	CcSEcCtD
Methylergometrine—Nausea—Epirubicin—sarcoma	0.00139	0.00254	CcSEcCtD
Methylergometrine—Vomiting—Doxorubicin—sarcoma	0.00138	0.00252	CcSEcCtD
Methylergometrine—Rash—Doxorubicin—sarcoma	0.00136	0.0025	CcSEcCtD
Methylergometrine—Dermatitis—Doxorubicin—sarcoma	0.00136	0.00249	CcSEcCtD
Methylergometrine—Headache—Doxorubicin—sarcoma	0.00136	0.00248	CcSEcCtD
Methylergometrine—Nausea—Doxorubicin—sarcoma	0.00129	0.00235	CcSEcCtD
